APC-targeted immunization for the treatment of HIV-1

References

• Lederman HM, Williams PL, Wu JW et al. Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. J. Infect. Dis. 188(12), 1794–1803 (2003).
   Google Scholar
• Imami N, Hardy G, Burton C et al Immune responses and reconstitution in HIV-1 infected individuals: impact of antiretroviral therapy, cytokines and therapeutic vaccination. Immunol Lett.79(1–2), 63–76 (2001).
   Google Scholar
• MacGregor RR, Ginsberg R, Ugen KE et al T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev. A/DS16(16), 2137–2143 (2002).
   Google Scholar
• Wang B, Ugen KE, Srikantan V et al Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Nati Acad. Sci. USA 90(9), 4156–4160 (1993).
   Google Scholar
• Koup RA, Safrit JT, Cao Y et al Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus Type 1 syndrome. J. Virol. 68(7), 4650–4655 (1994).
   Google Scholar
• Borrow P, Lewicki H, Wei X et al Antiviral pressure exerted by HIV-1-specific cytotoxic T-lymphocytes (CTL,$) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Merl 3(2), 205–211 (1997).
   Google Scholar
• Gea-Banacloche JC, Migueles SA, Martino L et al. Maintenance of large numbers of virus-specific CD8+ T-cells in HIV-infected progressors and long-term nonprogressors. I Immunol 165(2), 1082–1092 (2000).
   Google Scholar
• Betts MR, Yusim K, Koup RA. Optimal antigens for HIV vaccines based on CD8+ T response, protein length and sequence variability. DNA Cell Biol. 21(9), 665–670 (2002).
   Google Scholar
• Rowland-Jones SL, Pinheiro S, Kaul R et al. How important is the 'quality' of the cytotoxic T-lymphocyte (CTL) response in protection against HIV infection? Immunol Lett. 79(1-2), 15–20 (2001).
   Google Scholar
• Amara RR, Robinson HL. A new generation of HIV vaccines. Wends Mal Med. 8(10), 489–495 (2002).
   Google Scholar
• Barouch DH, Santra S, Schmitz JE et al Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290(5491), 486–492 (2000).
   PubMed Web of Science ®Google Scholar
• Lohman BL, McChesney MB, Miller CJ et al. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. j Vim!. 68(11), 7021–7029 (1994).
   Google Scholar
• Almond N, Kent K, Cranage M et al Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345(8961), 1342–1344 (1995).
   Google Scholar
• Wyand MS, Manson KH, Miller CJ, Neurath AR. Effect of 3-hydroxyphthaloyl-beta-lactoglobulin on vaginal transmission of simian immunodeficiency virus in rhesus monkeys. Antimicrob. Agents Chemother. 43(4), 978–980 (1999).
   Google Scholar
• Johnson RP, Lifson JD, Czajak SC et al. Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation. Viral 73 (6), 4952–4961 (1999).
   Google Scholar
• Kumar A, Mukherjee S, Shen J et al Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against MDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus. Virology301 (2), 189–205 (2002).
   Google Scholar
• Baba TW, Jeong YS, Pennick D, Bronson R, Greene MF, Ruprecht RM. Pathogenicity of live, attenuated SW after mucosal infection of neonatal macaques.Science 267(5205), 1820–1825 (1995).
   PubMedGoogle Scholar
• Whitney JB, Ruprecht RM. Live attenuated HIV vaccines: pitfalls and prospects. an: Opin. Infect. Dis. 17(1), 17–26 (2004).
   Google Scholar
• Piazza P, Fan Z, Rinaldo CR, Jr. CD8* T- cell immunity to HIV infection. Clin. Lab. Med. 22(3), 773–797 (2002).
   Google Scholar
• Moingeon P. Strategies for designing vaccines eliciting Thl responses in humans. Biotechnol 98(2-3), 189–198 (2002).
   Google Scholar
• Aichele P, Hengartner H, Zinkernagel Schulz M. Antiviral cytotoxic T-cell response induced by in vivo priming with a free synthetic peptide. I EAp. Med. 171(5), 1815–1820 (1990).
   Google Scholar
• Fayolle C, Deriaud E, Leclerc C. In vivo induction of cytotoxic T-cell response by a free synthetic peptide requires CD4+ T-cell help. I Immunol 147(12), 4069–4073 (1991).
   Google Scholar
• Sin JI, Kim JJ, Boyer JD et al In vivo modulation of vaccine-induced immune responses toward a Thl phenotype increases potency and vaccine effectiveness in a herpes simplex virus Type 2 mouse model.j Viral 73(1), 501–509 (1999).
   Google Scholar
• Sin JI, Kim JJ, Zhang D, Weiner DB. Modulation of cellular responses by plasmid CD4OL: CD4OL plasmid vectors enhance antigen-specific helper T-cell Type 1 CD4* T-cell-mediated protective immunity against herpes simplex virus Type 2 in vivo. Hum. Gene firer. 12(9),1091-1102 (2001).
   Google Scholar
• Kim JJ, Ayyavoo V, Bagarazzi ML et al In viva engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. Immunol 158(2), 816–826 (1997).
   Google Scholar
• Kim JJ, Bagarazzi ML, Trivedi N et al Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nature Biotechnol 15(7), 641–646 (1997).
   PubMedGoogle Scholar
• Kim JJ, Simbiri IKA, Sin JI et al Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SW. .1. Interferon Cytokine Res. 19(1), 77–84 (1999).
   Google Scholar
• Agadjanyan MG, Kim JJ, Trivedi N et al CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo. Immunol 162 (6), 3417–3427 (1999).
   Google Scholar
• Donaghy H, Stebbing J, Patterson S. Antigen presentation and the role of dendritic cells in HIV. CLI17: Opin. Infect. Dis. 17(1), 1–6 (2004).
   Google Scholar
• Steinman RM. The dendritic cell system and its role in immunogenicity. Ann. Rev Immunol 9,271–296 (1991).
   PubMed Web of Science ®Google Scholar
• Richards J, Le Naour F, Hanash S, Beretta L. Integrated genomic and proteomic analysis of signaling pathways in dendritic cell differentiation and maturation. Ann. NY Acad. Li. 975,91–100 (2002).
   Google Scholar
• Bauer S, Kirschning CJ, Hacker H et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Nail Acad. Sci. USA 98(16), 9237–9242 (2001).
   Google Scholar
• Ito T, Amakawa R, Fukuhara S. Roles of Toll-like receptors in natural interferon-producing cells as sensors in immune surveillance. Hum. Iminunol. 63(12), 1120–1125 (2002).
   Google Scholar
• Jenkins MK, Khoruts A, Ingulli E et al. In viva activation of antigen-specific CD4 T-eens. Ann. Rev Immunol 19,23–45 (2001).
   Google Scholar
• Akira S, Takeda K, Kaisho T Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunol 2(8), 675–680 (2001).
   PubMed Web of Science ®Google Scholar
• Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nature Rev Iminunol. 2(4), 251–262 (2002).
   PubMed Web of Science ®Google Scholar
• •Review of the immunological implications for vaccines.
   Google Scholar
• Lanzavecchia A, Sallusto E Dynamics of T- lymphocyte responses: intermediates, effectors and memory cells. Science 290(5489), 92–97 (2000).
   PubMed Web of Science ®Google Scholar
• Parham P. In: The Immune System. Parham P (Ed.), Elsevier Science, USA, 164–166 (2000).
   Google Scholar
• Sallusto F, Lanzavecchia A. Exploring pathways for memory T-cell generation. Clin. Invest. 108(6), 805–806 (2001).
   Google Scholar
• Lieberman J, Manjunath N, Shankar Avoiding the kiss of death: how HIV and other chronic viruses survive. Cum Opin. Immunol 14(4), 478–486 (2002).
   Google Scholar
• Weng NP, Liu K, Catalfamo M, Li Y, Henkart PA. IL-15 is a growth factor and an activator of CD8 memory T-cells. Ann. NY Acad. Sci. 975,46-56 (2002).
   Google Scholar
• Puaux AL, Michel ML. New gene-based approaches for an AIDS vaccine. Comp. Immunol Microbial Infect. Dis. 26(5–6), 357–372 (2003).
   Google Scholar
• Shiver JW, Fu TM, Chen L et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415(6869), 331–335 (2002).
   PubMed Web of Science ®Google Scholar
• Barnett BG, Crews CJ, Douglas JT. Targeted adenoviral vectors. Biochim. Biophys. Acta 1575(1–3), 1–14 (2002).
   Google Scholar
• Peachman KIK, Rao M, Alving CR. Immunization with DNA through the skin. Methods 31(3), 232–242 (2003).
   Google Scholar
• Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med 137(5), 1142–1162 (1973).
   Google Scholar
• ••Landmark article, the identification of dendritic cells (DCs).
   Google Scholar
• Inaba K, Metlay JP, Crowley MT Witmer- Pack M, Steinman RM. Dendritic cells as antigen-presenting cells in vivo. Int. Rev Immunol 6(2–3), 197–206 (1990).
   Google Scholar
• Nestle FO. Vaccines and melanoma. Clin. Exp. Dermatol 27(7), 597–601 (2002).
   Google Scholar
• Lisziewicz J, Bakare N, Lori E Therapeutic vaccination for future management of HIV/AIDS. Vaccine 21(7-8), 620–623 (2003).
   Google Scholar
• Lori F, Lisziewicz J. Structured treatment interruptions for the management of HIV infection. JAMA 286 (23), 2981–2987. (2001).
   Web of Science ®Google Scholar
• Lori F, Lewis MG, Xu J et al Control of SW rebound through structured treatment interruptions during early infection. Science 290(5496), 1591–1593 (2000).
   Google Scholar
• •Demonstration of the autovaccination concept.
   Google Scholar
• Lisziewicz J, Rosenberg E, Lieberman J et al Control of HIV despite the discontinuation of antiretroviral therapy. N. Engl. J. Med. 340(21), 1683–1684 (1999).
   Google Scholar
• Rosenberg ES, Altfeld M, Poon SH et al. Immune control of HIV-1 after early treatment of acute infection. Nature 407(6803), 523–526 (2000).
   Google Scholar
• Lisziewicz J, Gabrilovich DI, Varga G et al. Induction of Potent Human Immunodeficiency Virus Type 1-Specific T-Cell-Restricted Immunity by Genetically Modified Dendritic Cells.' Viral 75(16), 7621–7628 (2001).
   Google Scholar
• Lu W, Wu X, Lu Y, Guo W, Andrieu JM. Therapeutic dendritic-cell vaccine for simian AIDS. Nature Merl 9(1), 27–32 (2003).
   PubMed Web of Science ®Google Scholar
• •Demonstration of efficacy of ex vivo DC-based immunization.
   Google Scholar
• Rossio JL, Esser MT, Suryanarayana K et al Inactivation of human immunodeficiency virus Type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J Viral 72(10), 7992–8001 (1998).
   Google Scholar
• Bhardwaj N, Walker BD. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine. Nature Med. 9(1), 13–14 (2003).
   Google Scholar
• Lapenta C, Santini SM, Logozzi M et al Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-a. J Exp. Med. 198(2), 361–367 (2003).
   Google Scholar
• Garcia F, Lejeune M, Climent N et al Final results of a Phase I study of a therapeutic vaccine using autologous dendritic cells primed with autologous virus in patients with chronic HIV infection and CD4 T-cells above 400/mm3. 11th Conference on Retro viruses and Opportunistic Infections. San Francisco, CA, USA (Abstract 518) (2004).
   Google Scholar
• Barouch DH, Kunstman J, Kuroda MJ et al Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T-lymphocytes. Nature 415(6869), 335–339 (2002).
   PubMed Web of Science ®Google Scholar
• Cara A, Guarnaccia F, Reitz MS, Gallo RC, Lori E Self-limiting, cell type-dependent replication of an integrase-defective human immunodeficiency virus Type 1 in human primary macrophages but not T-lymphocytes. Virology 208 (1), 242–248 (1995).
   Google Scholar
• Lisziewicz J et al Novel Dendritic cell- based topical DNA vaccination combined with STI-HAART induced immune control in macaques with AIDS. The XIV International AIDS Conference, Barcelona, Spain (Abstract ThPpA2128) (2003).
   Google Scholar
• Lisziewicz J, Jianqing X, Lewis M et al Safety, immunogenicity and antiviral efficacy of a new topical DNA vaccine in macaques with chronic infection and AIDS. The XIV International AIDS Conference, Barcelona, Spain. (Abstract LbOR11) (2003).
   Google Scholar
• Ameisen JC, Capron A. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immurrol Today 12(4), 102–105 (1991).
   Google Scholar
• Meyaard L, Otto SA, Jonker RR et al Programmed death of T-cells in HIV-1 infection. Science 257 (5067), 217–219 (1992).
   Google Scholar
• Finkel TH, Tudor-Williams G, Banda NK et al Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SW-infected lymph nodes. Nature Med. 1(2), 129–134 (1995).
   Google Scholar
• Gougeon ML, Lecoeur H, Dulioust A et al. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T-cells correlates with lymphocyte activation and with disease progression. J Immunol 156(9), 509–3520 (1996).
   Google Scholar
• Zinkernagel RM. Immunology taught by viruses. Science 271 (5246), 173–178 (1996).
   Google Scholar
• Hellerstein MK, Hoh RA, Hanley MB et Subpopulations of long-lived and short-lived T-cells in advanced HIV-1 infection. J Clin. Invest. 112 (6), 956–966 (2003).
   Google Scholar
• Giorgi JV, Hultin LE, McKeating JA et al. Shorter survival in advanced human immunodeficiency virus Type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179(4), 859–870 (1999).
   Google Scholar
• •New insights to HIV pathogenesis.
   Google Scholar
• Sousa AE, Carneiro J, Meier- Schellersheim M, Grossman Z, Victorino RM. CD4 T-cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 169(6), 3400–3406 (2002).
   Google Scholar
• Sopper S, Nierwetberg D, Halbach A et al. Impact of simian immunodeficiency virus (SIV) infection on lymphocyte numbers and T-cell turnover in different organs of rhesus monkeys. Blood 101 (4), 1213–1219 (2003).
   PubMed Web of Science ®Google Scholar
• Soumelis V, Scott I, Liu YJ, Levy J. Natural Type 1 interferon producing cells in HIV infection. Hum. Immunol 63(12), 1206–1212 (2002).
   Google Scholar
• Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182(2), 389–400 (1995).
   Google Scholar
• Engering AJ, Cella M, Fluitsma D et al The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur. Immunol 27(9), 2417–2425 (1997).
   Web of Science ®Google Scholar
• Engering AJ, Cella M, Fluitsma DM et Mannose receptor mediated antigen uptake and presentation in human dendritic cells. Adv. Exp. Med. Biol. 417,183–187 (1997).
   PubMed Web of Science ®Google Scholar
• Takahashi K, Donovan MJ, Rogers RA, Ezekowitz RA. Distribution of murine mannose receptor expression from early embryogenesis through to adulthood. Cell Tissue Res. 292(2), 311–323 (1998).
   Google Scholar
• Boussif O, Lezoualc'h F, Zanta MA et al A versatile vector for gene and oligonucleotide transfer into cells in culture and in viva. polyethylenimine. Proc. Natl Acad. Sc]. USA 92(16), 7297–7301 (1995).
   Google Scholar
• Chemin I, Moradpour D, Wieland S et al. Liver-directed gene transfer: a linear polyethlenimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in viva J. Viral Hepat. 5(6), 369–375 (1998).
   Google Scholar